INVESTIGADORES
ZWIRNER Norberto Walter
congresos y reuniones científicas
Título:
Senescent fibroblasts promote tumor growth and induce myeloid-derived suppressor cell (MDSC) accumulation in spleen of CT26 tumor bearing mice
Autor/es:
SPALLANZANI, RAÚL GERMÁN; RAFFO IRAOLAGOITÍA, XIMENA LUCÍA; TORRES, NICOLÁS IGNACIO; ZIBLAT, ANDREA; DOMAICA, CAROLINA INÉS; FUERTES, MERCEDES BEATRIZ; ZWIRNER, NORBERTO WALTER
Lugar:
Mar del Plata
Reunión:
Congreso; 62a Reunión Anual de la Sociedad Argentina de Inmunología; 2014
Institución organizadora:
Sociedad Argentina de Inmunología
Resumen:
As world population becomes older during the next
decades, a significant increase in chronic diseases associated with age is
expected. In this context, senescence is an ageing-associated phenomenon that
involves, among other events, irreversible cell cycle arrest and the secretion
of a wide variety of soluble factors, including cytokines, chemokines and
growth factors that under certain conditions induce chronic inflammation and promote
tumor progression. It has been proposed that senescent fibroblasts directly facilitate
tumor growth in immunodeficient mice by promoting epithelial cell
proliferation, the production of Vascular Endothelial Growth Factor and Matrix
Metalloproteinases. As the effect of senescent stroma on immunesurveillance -a
crucial feature that determines tumor progression-, is still unknown, we
explored whether senescent fibroblasts favors tumor growth by modulating
different immune cell populations such as MDSCs, T regulatory cells (T regs), NK
cells, conventional CD4 and CD8 T cells both locally and systemically. To this
end, we co-injected CT26 tumor cells along with untreated (CT26+control fb) or
etoposide-induced senescent (CT26+senescent fb) IZA-1
cells. We observed a more rapid tumor volume increase in animals from the
CT26+senescent fb group compared to controls. This difference (186.8±28.8 mm3
vs 85.5± 2.5 mm3; p<0.05) was detected as early as 10 days after tumor
challenge. Moreover, although no significant difference was observed in the
intratumoral immune cell infiltrate (T regs, MDSCs, NK cells, CD4 or CD8 T
cells) around day 18, such differences in the tumor volume in CT26+senescent fb
mice (596.3±12.8 mm3 vs 76.8±38.3 mm3; p<0.01) were associated
with a higher percentage of spleen MDSCs compared to control (9.3±1.7 vs 5.1±0.7;
p<0.05). Our results indicate that senescent fibroblasts early stimulate
tumor growth and this increased neoplastic mass is associated with an expansion
of MDSCs in spleen.